VTVT — vTv Therapeutics Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1641489 ·
Last close
$32.35
Market Cap
$127.42M
52W High
$38.84
52W Low
$29.44
ADV30
83,880
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 36,839,000 | — | 23,263,000 | 24,134,000 | 98,813,000 | 98,086,000 | 8,854,000 |
| Dec 2025 | 0 | — | -7,885,000 | -7,138,000 | 89,899,000 | 88,932,000 | 25,462,000 |
| Sep 2025 | 0 | — | -10,699,000 | -8,698,000 | 99,494,000 | 98,504,000 | 28,951,000 |
| Jun 2025 | 0 | — | -7,721,000 | -6,046,000 | 26,448,000 | 25,922,000 | 24,043,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-10,414,000
Investing CF
—
Financing CF
$77,441,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.93
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-302,558,000
Inventory
—
Receivables
$62,000
ST Investments
—
EBIT TTM
$-1,935,000
Pretax Income TTM
$-729,000
Interest Exp TTM
$6,000
Analysts
6
Yahoo Snapshot (yfinance, live)
Total Revenue
$36,839,000
EBITDA
$-3,034,000
Free Cash Flow
$5,278,000
Enterprise Value
$303,354,144
Total Cash
$98,086,000
Total Debt
$0
Shares Out
3,938,654
Trailing EPS
$-0.78
Book Value
$7.25
ROE
-1.5%
ROA
-2.9%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -32,808,000 | -26,974,000 | 89,899,000 | 25,462,000 | — | -25,255,000 |
| Dec 2024 | 1,017,000 | -24,180,000 | -18,462,000 | 38,266,000 | 23,965,000 | — | -25,307,000 |
| Dec 2023 | 0 | -25,502,000 | -20,250,000 | 11,018,000 | 29,567,000 | — | -19,081,000 |
| Dec 2022 | 2,018,000 | -22,540,000 | -19,164,000 | 33,238,000 | 27,399,000 | — | -16,022,000 |
TTM Snapshot
Revenues TTM
$3,000,000
NetIncome TTM
$-16,785,000
OpCashFlow TTM
$0
Assets (Latest)
$38,266,000
Forward EPS
$-3.89
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CNTB | Connect Biopharma Holdings Ltd | $127.19M | $2.02 | — |
| TLSA | Tiziana Life Sciences Ltd | $131.08M | $1.03 | — |
| GNLX | GENELUX Corp | $131.83M | $2.94 | — |
| PMN | ProMIS Neurosciences Inc. | $123.04M | $13.72 | — |
| OGI | ORGANIGRAM GLOBAL INC. | $132.19M | $0.94 | — |
News headlines (Yahoo Finance, 1h cache)
vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
2026-07-28 20:05 · Yahoo
cAMPfield lands $180M to build gut disease drug
2026-06-18 11:45 · Yahoo
vTv Therapeutics Inc. (NASDAQ:VTVT) Just Beat Earnings: Here's What Analysts Think Will Happen Next
2026-05-17 13:26 · Yahoo
vTv Therapeutics (VTVT) is on the Move, Here's Why the Trend Could be Sustainable
2026-05-15 12:55 · Yahoo
vTv Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
2026-05-13 20:01 · Yahoo
vTv Therapeutics to Participate in Upcoming May Investor Conferences
2026-05-07 12:00 · Yahoo
Wall Street Analysts See a 39.9% Upside in vTv Therapeutics (VTVT): Can the Stock Really Move This High?
2026-04-20 13:55 · Yahoo
Wall Street Analysts Think vTv Therapeutics (VTVT) Could Surge 31.58%: Read This Before Placing a Bet
2026-04-02 13:55 · Yahoo
vTv Therapeutics (VTVT) Reports $27M 2025 Net Loss Amid Cadisegliatin Advancements
2026-03-18 00:05 · Yahoo
Wall Street Analysts Believe vTv Therapeutics (VTVT) Could Rally 39.86%: Here's is How to Trade
2026-03-17 13:55 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.